BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 30161053)

  • 1. Cervical Cancer Screening for Women With Disabilities: Time for a New Approach?
    Nguyen AQ; Mandigo M; Coleman JS
    J Low Genit Tract Dis; 2018 Oct; 22(4):318-319. PubMed ID: 30161053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
    Hallett LD; Gerber MR
    J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
    Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FA; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
    J Low Genit Tract Dis; 2015 Apr; 19(2):91-6. PubMed ID: 25574659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
    Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FA; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
    Gynecol Oncol; 2015 Feb; 136(2):178-82. PubMed ID: 25579107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
    Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
    Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast and cervical cancer screening disparities associated with disability severity.
    Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
    Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    Kim JJ; Burger EA; Sy S; Campos NG
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.
    Sewali B; Okuyemi KS; Askhir A; Belinson J; Vogel RI; Joseph A; Ghebre RG
    Cancer Med; 2015 Apr; 4(4):620-31. PubMed ID: 25653188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived effectiveness of HPV test as a primary screening modality among US providers.
    Cooper CP; Saraiya M
    Prev Med; 2015 Sep; 78():33-7. PubMed ID: 26116889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
    Datta SD; Saraiya M
    Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
    Davis M; Feldman S
    Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Knowledge and Beliefs About Human Papillomavirus and Cervical Cancer Screening Intervals in Low-Income Women After an Educational Intervention.
    Roland KB; Benard VB; Greek A; Hawkins NA; Lin L
    J Prim Care Community Health; 2016 Apr; 7(2):88-95. PubMed ID: 26763304
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.